Flow Diverters Global Market Report 2025

The flow diverters market size has grown rapidly in recent years. It will grow from $0.5 billion in 2024 to $0.55 billion in 2025 at a compound annual growth rate (CAGR) of 11.7%. The growth during the historical period can be attributed to the rising prevalence of intracranial aneurysms globally, increased adoption of endovascular procedures, heightened awareness among both physicians and patients, increasing global healthcare spending, and a growing preference for minimally invasive and outpatient treatments.

The flow diverters market size is expected to see rapid growth in the next few years. It will grow to $0.86 billion in 2029 at a compound annual growth rate (CAGR) of 11.5%. The projected growth during the forecast period can be attributed to a rising number of positive clinical outcomes and real-world evidence, increased investments in research and development, a growing elderly population, expanding reimbursement coverage, and a higher incidence of hypertension and atherosclerosis. Key trends expected in this period include innovations in flow diverter device design, the integration of advanced imaging technologies, advancements in bioabsorbable and biocompatible materials, improvements in delivery systems, and progress in personalized medicine.

The increasing prevalence of aneurysms is anticipated to drive the growth of the flow diverters market in the coming years. Aneurysms are abnormal bulges or ballooning in the wall of blood vessels, usually resulting from a weakened vessel wall. The rise in aneurysm cases is primarily due to a growing aging population and advancements in diagnostic technologies, which contribute to improved detection rates and heightened awareness, leading to more diagnosed cases. Flow diverters address this rising prevalence by redirecting blood flow away from the weakened vessel area, encouraging healing, lowering the risk of rupture, and providing a minimally invasive alternative to conventional surgical methods. For example, in February 2022, the Brain Aneurysm Foundation, a U.S.-based advocacy group, reported that approximately 6.5 million Americans - around 1 in 50 - have an unruptured brain aneurysm, with nearly 30,000 cases rupturing each year. Thus, the increasing prevalence of aneurysms is fueling the expansion of the flow diverters market.

Leading companies in the flow diverters market are emphasizing advancements in material science, particularly the development of polymer-based neurovascular stents, to enhance device performance, improve biocompatibility, support natural vessel healing, and minimize reliance on long-term blood-thinning medications. A polymer-based neurovascular stent is a medical implant used to maintain the openness of brain blood vessels, especially in treating aneurysms, stenosis, or vascular malformations. For example, in June 2023, Fluid Biomed, a Canada-based medical device startup, announced the first-ever implantation of a fully polymer-based neurovascular stent in human patients. This novel device, named the ReSolv stent, is specifically designed to treat brain aneurysms. Unlike conventional hybrid polymer-metal stents, the ReSolv stent is made entirely of polymer and is engineered to gradually dissolve as the vessel heals. This innovative approach offers the potential to reduce the need for prolonged blood-thinning therapy while facilitating the vessel’s natural recovery.

In May 2023, Stryker Corporation, a U.S.-based medical technology company, acquired Cerus Endovascular Ltd. for an undisclosed sum. This acquisition strengthens Stryker’s Neurovascular division by incorporating Cerus Endovascular’s innovative intrasaccular aneurysm treatment devices, thereby expanding its hemorrhagic portfolio, reinforcing its position in minimally invasive stroke care, and enabling physicians to address a wider range of intracranial aneurysms with advanced, specialized solutions. Cerus Endovascular Ltd. is a UK-based biotechnology company focused on the design and development of interventional neuroradiology devices and delivery systems.

Major players in the flow diverters market are Johnson & Johnson, Medtronic plc, Stryker Corporation, Terumo Corporation, MicroPort Scientific Corporation, Penumbra Inc., Phenox GmbH, Sino Medical Sciences Technology Inc., Balt Extrusion S.A.S., Sequent Medical Inc., Wallaby Medical Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Acandis GmbH & Co. KG, Fluid Biomed Inc., InspireMD Inc., INVAMED Medical Innovation, Oxford Endovascular Ltd., Qvanteq AG, EndoStream Medical Ltd., and Endomimetics LLC.

North America was the largest region in the flow diverters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in flow diverters report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the flow diverters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Flow diverters are advanced endovascular devices designed to treat intracranial aneurysms, especially those that are large or complex. These devices are tubular, mesh-structured stents inserted into the parent blood vessel to reroute blood flow away from the aneurysm sac. This change in flow encourages clot formation within the aneurysm while maintaining normal circulation in adjacent vessels. Flow diverters offer a less invasive alternative to procedures like surgical clipping or coiling.

The primary types of flow diverters include pipeline embolization devices, silk flow diverters, surpass flow diverters, flow redirection endoluminal devices, among others. Pipeline embolization devices are minimally invasive, stent-like implants used for treating brain aneurysms by redirecting blood flow away from the aneurysm sac, supporting the healing of the vessel wall. These devices are manufactured using materials such as nitinol, cobalt-chromium alloy, stainless steel, and others. They are utilized in treating intracranial aneurysms, arteriovenous malformations, carotid artery disease, and more, with end-users including hospitals, clinics, and ambulatory surgical centers.

The flow diverters market research report is one of a series of new reports that provides flow diverters market statistics, including the flow diverters industry global market size, regional shares, competitors with the flow diverters market share, detailed flow diverters market segments, market trends, and opportunities, and any further data you may need to thrive in the flow diverters industry. This flow diverters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The flow diverters market consists of revenues earned by entities providing services such as training and certification programs, research and clinical trials services, and reimbursement and insurance support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The flow diverters market also includes sales of low-profile flow diverters, variable porosity flow diverters, and expandable hybrid devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.